CD59 and myeloid sarcoma: In the data obtained from the cohort, proteins such as TTR, SRSF10, RPS21, SRP9, DBI, BTF3, GZMK, RO60, STMN1, ENAM and CD59 had significant prognostic value in both the T1DM and MS groups.